EU: ABEL TIE?? [Two-Stage / GS Designs]

posted by mittyri – Russia, 2019-10-19 23:24 (298 d 12:02 ago) – Posting: # 20707
Views: 1,830

Hi Helmut,

» an update: Yesterday at the 4th Biosimilars Forum a participant asked whether simulation-based methods (control of the type I error in a sufficiently high number of simulations, i.e., 1 mio in each cell of a narrow grid of n1/CV combinations) are acceptable. Andreas Brandt (BfArM and observer at the BSWP) answered “No.”

sad story
BTW: in your lecture you suggested to adjust the CIs for ABEL due to TIE inflation. Is that also dead?
Does it mean that you cannot prove anything using sims??

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,009 posts in 4,379 threads, 1,460 registered users;
online 21 (1 registered, 20 guests [including 12 identified bots]).
Forum time: Thursday 11:27 CEST (Europe/Vienna)

If you obey all the rules,
you will miss all the fun.    Katharine Hepburn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5